Kate Goldstein
SVP Business Consulting
Kate is passionate about applying innovative approaches to address the most complex challenges in life sciences. Since joining SSI in 2011, she has partnered with biotech leaders to build and scale their organizations, with a particular focus on strategies that accelerate or de-risk critical milestones. Her work is anchored in a singular priority: creating meaningful value—for client organizations, for investors, and ultimately for patients. In addition to her client work, Kate also drives several components of SSI’s own value creation strategy. She oversees the development and growth of SSI’s functional service offerings and leads the firm’s inorganic growth and M&A efforts.
Prior to SSI, Kate was part of Deloitte’s Strategy & Operations practice, where she delivered M&A integration, financial management, and human capital solutions.
Key areas of expertise
- Biotech growth strategy and milestone acceleration
- Value creation through organizational design and scaling
- M&A strategy, integration, and inorganic growth